Nancy E. Dempze’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-5,210
| Closed | -$402K | – | 68 |
|
|
2018
Q3 | $402K | Sell |
5,210
-2,956
| -36% | -$228K | 0.45% | 49 |
|
|
2018
Q2 | $579K | Buy |
8,166
+598
| +8% | +$42.4K | 0.71% | 35 |
|
|
2018
Q1 | $570K | Buy |
7,568
+83
| +1% | +$6.25K | 0.7% | 39 |
|
|
2017
Q4 | $536K | Sell |
7,485
-103
| -1% | -$7.38K | 0.65% | 42 |
|
|
2017
Q3 | $615K | Sell |
7,588
-780
| -9% | -$63.2K | 0.87% | 38 |
|
|
2017
Q2 | $592K | Sell |
8,368
-2,502
| -23% | -$177K | 0.85% | 39 |
|
|
2017
Q1 | $738K | Sell |
10,870
-50
| -0.5% | -$3.4K | 1.13% | 33 |
|
|
2016
Q4 | $782K | Sell |
10,920
-500
| -4% | -$35.8K | 1.37% | 26 |
|
|
2016
Q3 | $903K | Buy |
11,420
+969
| +9% | +$76.6K | 1.58% | 23 |
|
|
2016
Q2 | $873K | Buy |
10,451
+3,348
| +47% | +$280K | 1.55% | 23 |
|
|
2016
Q1 | $653K | Buy |
7,103
+1,301
| +22% | +$120K | 1.15% | 30 |
|
|
2015
Q4 | $587K | Buy |
+5,802
| New | +$587K | 1.13% | 32 |
|